期刊文献+

ERCC1蛋白及mRNA在食管鳞癌中的表达及临床意义 被引量:2

Expression of excision repair cross completion 1 in human esophageal carcinoma and its clinical significance
下载PDF
导出
摘要 目的:通过检测ERCC1蛋白及mRNA在食管癌、癌旁组织中的表达,初步探讨其与食管癌发生发展、侵袭转移之间的关系。方法:采用免疫组化(SP法)染色法及逆转录-聚合酶链反应(RT-PCR法)对62例食管癌及部分病例相应的36例癌旁组织中的ERCC1蛋白及mRNA的表达进行检测,并行统计学分析。结果:ERCC1蛋白及mRNA在食管癌组织中的表达均高于癌旁组织(对照组),且与癌组织的浸润程度、淋巴结转移、癌组织分化程度及临床预后密切相关(P<0.05)。结论:ERCC1的表达与食管癌发生发展、侵袭转移关系密切,可作为食管癌患者的个体化治疗及临床预后判定的病理学指标之一。 Objective: To study the correlation between the expression of excision repair cross completion 1 (ERCC1) and the occurrence, development, invasion and metastasis of human esophageal cell carcinoma (ESCC). Methods: Immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR) were used to detect the expression of ERCC1 in 62 cases of ESCC specimens and 36 cases of nearby non-cancerous tissue. The results were statistically analyzed. Results: The expression of ERCC1 in esophageal carcinoma was significantly higher than in non-cancerous tissue (P 〈 0.05),and was significantly correlated to the infiltraticn, lymphatic metastasis,differentiation and prognosis of the tumor. Conclusion: ERCC1 plays an important role in the invasion and metastasis of the esophageal carcinomas. The expression level of ERCC1 may be used as an indicator for the study of chemotherapy, biological behavior and prognosis of ESCC.
出处 《泸州医学院学报》 2013年第4期360-364,共5页 Journal of Luzhou Medical College
关键词 食管癌 ERCC1 免疫组织化学 逆转录-聚合酶链反应 Esophageal carcinoma Excision repair cross completion 1 Immunohistochemistry Reversetranscription polymerase chain reaction
  • 相关文献

参考文献13

  • 1Thompson LH, Bachinske LL, Stellings RL, et al. Com- plementation of repair gene mutations on the hemizygous chromosome 9 in CHO: a third repair gene on human chromosome 19[J]. Genomics, 1989, 5(4):670-679.
  • 2Trispsianes K, Folkers G,Ab E, et al.The structure of the human ERCCI/XPF interaction domains reveals a com- plementary role for the two proteins in nucleotide excision repair[J]. Structure, 2005, 13:1849-1858.
  • 3Simon GR, Sharma S,Cantor A, et al.ERCC1 expression is a predictor of survival in resected patients with non- small cell lung caneer[J].Chest. 2005, 127(3):978-983.
  • 4Lu SH. Alterations of oncogenes and tumor suppressor genes in esophageal cancer in China [J]. Mutat Res, 2000, 462 : 343-353.
  • 5Wood RD, Nucleotide excision repair in mammalian cells [J]. J Boil Chem, 1997, 272(38):23465-23468.
  • 6Fountzilas G, Bamias A, Kalogera-Fountzila A, et al. In- duction chemotherapy with docetaxel and cisplatin fol- lowed by concomitant chemoradiotherapy in patients with inoperable non- nasopharyngeal carcinoma of the head and neck [J]. Anticancer Res, 2009, 29(2): 529-538.
  • 7Ahnde FE. Molecular markers that predict response to colon cancer therapy [J]. Exp Rev Mol Diagn, 2005, 5:353-375.
  • 8Tse D, Zhai R, Zhou W, et al .Polymorphisms of the NER pathway genes,ERCC1 and XPD are associated with esophageal adenocarcinoma risk [J]. Cancer Causes Control,2008, 19(10):1077-1083.
  • 9Liu Y, Scheurer ME, El-Zein R, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(1):204-214.
  • 10Yang ZH, Dai Q, Kong XL, et al .Association of ER- CC1 polymorphisms and Susceptibility to nasopharyngeal carcinoma[J]. Mol Careinog,2009 Mar,48(3):196-201.

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部